D-0184-2023 Class I Terminated
FDA drug recall D-0184-2023 was initiated by Pfizer Inc. on Dec 22, 2022 and is designated Class I. Reason for recall: Presence of Particulate Matter: Glass particulate matter detected in injectable. The recall status is terminated (terminated Aug 7, 2024). Affected quantity: 89,700 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 1, 2023
- Initiation Date
- Dec 22, 2022
- Termination Date
- Aug 7, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 89,700 vials
Product description
Vancomycin Hydrochloride for Injection, USP, 1.5 g/vial, Sterile powder, Single-dose Fliptop Vial, 10 vials per carton, Rx only, Distributed by: Hospira, Inc., Lake Forest, IL 60045. NDC Vial 0409-3515-11; NDC Carton 0409-3515-01
Reason for recall
Presence of Particulate Matter: Glass particulate matter detected in injectable.
Distribution pattern
USA nationwide and Puerto Rico
Code information
Lot: 33045BA, EXP 1SEP2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0184-2023
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Pfizer Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.